News

Australian Sales Update
LBT Innovations provides an update on sales activities in the Australian market and previously advised expected sales of the APAS® Independence in calendar 2018.
First Placement of APAS Independence into US Lab
Clever Culture Systems has placed the first APAS® Independence into a US medical centre to act as a key opinion leader ahead of US commercial launch.
First sale of APAS Independence
PAC Partners Analyst Report - Analyst report from PAC Partners following the first sale of APAS Independence to St Vincent's Hospital in Melbourne
Quarterly Activities & Cashflow Report
We are pleased to release our Quarterly Cashflow report and Update for the quarter ended 30 September 2018 (the Quarter).
Bioshares Biotech Summit presentation summary
The Investment Proposition Does the Means Justify the End? Brent Barnes CEO LBT Innovations addresses the topic at the 14th Biotech Summit
LBT Innovations Market Update
Bioshares Analyst Report - Targets for LBT Innovations based on sales of the APAS Independence instrument and ongoing software licences.
APAS Independence wins award at MDEA
The APAS Independence, the product of Clever Culture Systems, has won Silver at the Medical Design Excellence Awards in New York.
APAS Independence – MDEA award Finalist
The APAS Independence, the product of Clever Culture Systems, has been nominated as a finalist in the Medical Design Excellence Awards.
Using AI to automate clinical microbiology
Australian Government grant initiative. Business.com.au Research and Development Tax Incentives - Customer Story on LBT Innovations
Extraordinary General Meeting Presentation 2018
Presentation by Brent Barnes Chief Executive Officer & Managing Director of LBT Innovations at this April's Extraordinary General Meeting
Artificial Intelligence for Pathology Bottlenecks
LBT’s APAS® received regulatory approval and patents over the last 18 months. Its first evaluation trial at St Vincent Hospital was successfully completed.
APAS Installed at First Hospital Site
Bioshares Analyst Report following LBT Innovations installation of its first APAS Independence instrument in Melbourne, at St Vincent's Hospital.
Under The Radar Report Small CAP Research
Robotics is a hot investment theme and LBT has been riding the wave of interest with its device to automate the processing and analysis of biological samples.
Under The Radar Report Small CAP Research
Under the Radar Report Biotech Special - Tim Boreham's sector run-down on opportunities to make money from the makers of devices and diagnostic tools.
Cornerstone-type Investor to Help Develop WoundVue
WoundVue is a hand-held device capable of interpreting tissue types and providing surface area, volume and depth measurements.
APAS Reaches Self Certification
LBT Innovations has completed the self-certification process for CE Marking for its APAS Independence launching by year’s end.